GET DAILY SIGNALSBWX Technologies (BWXT): Can It Reach the $205 Analyst Target?
Key Takeaways
- The central target of $205 is the arithmetic mean of 12 current, identifiable analyst price targets, rounded from roughly $203; the individual targets range from about $165 to $255.
- At a recent close of $127.19, reaching $205 would require a gain of about 61%, a very large move by any standard.
- Supporting the bullish case are a record nuclear backlog, raised 2026 guidance, a sole-source position on U.S. Navy nuclear propulsion, and growing commercial nuclear and advanced-reactor demand.
- The biggest risks are a steep valuation reset, a cluster of recent analyst target cuts, and execution risk around long-dated programs whose earnings may take years to materialize.
- The consensus rating remains a "Buy," but recent actions have skewed toward trimming targets rather than raising them, signaling caution on valuation rather than a loss of conviction in the business.
- You can find more detail on this ticker's Major News, Today's Price Move, Forecast, and Earnings on dedicated pages.
- Explore Trending AI Robots to see AI-driven trading strategies monitoring stocks and ETFs like BWXT.
Understanding the Analyst Consensus on BWXT
BWX Technologies, Inc. (BWXT) is a specialty nuclear manufacturer and technology developer, best known as the sole-source supplier of naval nuclear reactors, components, and fuel for the U.S. Navy, alongside a growing commercial nuclear business.
Across recent research from firms including J.P. Morgan ($190), Northland Securities ($220), Truist Financial ($182), Jefferies ($181), BofA Securities ($210), Guggenheim ($192), BTIG ($235), BNP Paribas Exane ($165), Wells Fargo ($170), Deutsche Bank ($255), Oppenheimer ($210), and TD Cowen ($230), the individual 12-month price targets average roughly $203, which rounds to a central target of $205. The low-to-high range of about $165 to $255 is unusually wide, reflecting genuine disagreement over how much of a premium the market should pay for BWXT's growth.
Ratings remain broadly constructive, with a "Buy" consensus, but the direction of recent revisions matters. J.P. Morgan cut to $190 from $230, BofA to $210 from $250, Northland to $220 from $250, and BNP Paribas to $165 from $190, even while keeping bullish or neutral ratings. The common theme is a valuation reset after a sharp pullback, not a collapse in the underlying story. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Current Market Position and Path Toward the Target
BWXT recently traded near $127.19, toward the low end of a 52-week range of roughly $123 to $242 and well below its 200-day moving average near $180. Reaching $205 implies upside of about 61%, which is a very large move that would require the stock to reclaim levels it traded at only months earlier.
The path would likely depend on the market re-rating the shares toward a higher multiple of EPS as earnings visibility improves, rather than on a sudden fundamental break. With fiscal 2026 guidance of $4.70 to $4.80 in EPS and revenue of about $3.8 billion, a $205 share price would still sit at a premium valuation, underscoring how much of the target rests on sentiment and forward expectations.
What Could Support a Move Toward the Target
BWXT ended 2025 with a backlog of about $7.3 billion, up roughly 50% year over year, and has raised its 2026 revenue outlook. Its government segment enjoys a near-monopoly role in U.S. Navy nuclear propulsion, while the commercial side is positioned for SMRs, microreactors, and advanced nuclear demand. Recent wins include the BANR microreactor selection for a Canadian project. Acquisitions such as Kinectrics and a pending medical-business divestiture are reshaping the portfolio, while 2030 financial targets introduced at an investor day were described by several analysts as ahead of expectations.
What Could Prevent the Target From Being Reached
The clearest obstacle is valuation. BWXT's P/E ratio has hovered in the mid-30s, and the cluster of target cuts in September and October was driven by a pullback in peer multiples and a reset in what analysts are willing to pay. Long-dated themes such as AI-related power demand and next-generation reactors may take years to convert into earnings, leaving the stock exposed if execution slips or sentiment toward nuclear equities cools. A slower defense budgeting cycle or delays in commercial contracts could also compress the multiple further.
Technical Levels and Market Structure
BWXT's sharp decline leaves the 50-day moving average near $148 and the 200-day average near $180 as notable overhead zones. The prior support area around $123 to $135 represents the current floor, while a move toward $205 would require clearing psychological resistance near $150 and then the $180 level, where the longer-term trend currently sits. The wide gap between the recent price and prior highs highlights how much ground the stock has given back.
Time Horizon and What Investors Should Monitor
Analyst price targets generally reflect a roughly 12-month research horizon, though individual assumptions vary. The next major catalyst is third-quarter earnings, with results expected around early November. Investors should watch backlog growth, margin trends, updates on the medical-business sale and the Precision Components Group deal, commercial nuclear contract announcements, and any further analyst target revisions. Changes in interest rates and broader risk appetite can also influence how much premium the market assigns to long-duration growth stories like BWXT. From what I see, tracking these factors closely will be key.
AI Daily Buy/Sell Signals
In my research process, I often rely on Tickeron's AI Daily Buy/Sell Signals to stay on top of momentum shifts. These tools use artificial intelligence to monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on technical behavior and market conditions. For those following BWXT, they provide a practical way to track evolving trends alongside the broader market.
Final Assessment
Can BWXT reach $205? The central target, derived from a dozen current analyst price targets averaging roughly $203, implies a gain of about 61% from recent levels, a very large move. The supportive case rests on a record backlog, raised guidance, a sole-source government franchise, and expanding commercial nuclear opportunities. Against that, a wide $165-to-$255 target range, a series of valuation-driven target cuts, and a steep premium multiple argue for caution. The stock's 2026 path will likely hinge on execution, backlog conversion, and whether the market is willing to re-rate a long-duration growth story that has already given back much of its earlier gains.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
BWXT in upward trend: price may jump up because it broke its lower Bollinger Band on October 22, 2026
BWXT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 31 of 37 cases where BWXT's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 84%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +1.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where BWXT advanced for three days, in 229 of 327 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BWXT as a result. In 42 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 48%.
The Moving Average Convergence Divergence Histogram (MACD) for BWXT turned negative on October 22, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 23 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 49%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BWXT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.
The Aroon Indicator for BWXT entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 35 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 59 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 80 (best 1 - 100 worst), indicating slightly worse than average price growth. BWXT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 88 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 96 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.733) is normal, around the industry mean (4.788). P/E Ratio (32.866) is within average values for comparable stocks, (16.638). BWXT's Projected Growth (PEG Ratio) (27.780) is very high in comparison to the industry average of (2.564). Dividend Yield (0.008) settles around the average of (0.060) among similar stocks. P/S Ratio (3.811) is also within normal values, averaging (18.330).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of components and services to nuclear power industry
Industry AerospaceDefense
Advertisement